Panel Discussion

Panel Member(s):

• Christopher Downey, CDER, FDA
• Hugo Hamel, Health Canada
• Yasuhiro Kishioka, PMDA-Pharmaceuticals and Medical Devices Agency
• Frank Montgomery, AstraZeneca
• Mahesh Ramanadham, CDER, FDA
• Jessica Lo Surdo Pinder, Amgen Inc.
• Bianca Omasreiter, Roche Diagnostics GmbH

Session Speaker(s):

• Kristopher Barnthouse, Janssen Pharmaceutical R&D, LLC